UnitedHealth Group Incorporated (NYSE:UNH) Stake Raised by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,115 shares of the healthcare conglomerate’s stock after acquiring an additional 1,051 shares during the quarter. Signal Advisors Wealth LLC’s holdings in UnitedHealth Group were worth $4,611,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Hanson & Doremus Investment Management lifted its holdings in shares of UnitedHealth Group by 10.9% during the second quarter. Hanson & Doremus Investment Management now owns 459 shares of the healthcare conglomerate’s stock valued at $234,000 after purchasing an additional 45 shares during the last quarter. Retirement Planning Co of New England Inc. grew its stake in shares of UnitedHealth Group by 5.4% in the 2nd quarter. Retirement Planning Co of New England Inc. now owns 448 shares of the healthcare conglomerate’s stock valued at $228,000 after buying an additional 23 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in UnitedHealth Group in the second quarter valued at approximately $228,000. Fairfield Financial Advisors LTD acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $2,194,000. Finally, Capital Wealth Planning LLC lifted its stake in shares of UnitedHealth Group by 4.1% in the 2nd quarter. Capital Wealth Planning LLC now owns 1,016,952 shares of the healthcare conglomerate’s stock valued at $517,893,000 after purchasing an additional 39,713 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 4.0 %

Shares of UNH opened at $541.28 on Tuesday. The firm has a market capitalization of $498.13 billion, a PE ratio of 35.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $554.92 and its 200-day simple moving average is $562.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $6.56 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Ratings Changes

Several equities analysts have commented on UNH shares. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Barclays boosted their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.